HLA-DOA Antikörper (AA 26-135)
Kurzübersicht für HLA-DOA Antikörper (AA 26-135) (ABIN7155580)
Target
Alle HLA-DOA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 26-135
-
Kreuzreaktivität
- Human
-
Aufreinigung
- Antigen Affinity Purified
-
Immunogen
- Recombinant Human HLA class II histocompatibility antigen, DO alpha chain protein (26-135AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Recommended dilution: IHC:1:20-1:200,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- HLA-DOA (HLA Class II DO alpha (HLA-DOA))
-
Andere Bezeichnung
- HLA-DOA
-
Hintergrund
-
Background: Important modulator in the HLA class II restricted antigen presentation pathway by interaction with the HLA-DM molecule in B-cells. Modifies peptide exchange activity of HLA-DM.
Aliases: HLA-DOA antibody, HLA-DNA antibody, HLA-DZAHLA class II histocompatibility antigen antibody, DO alpha chain antibody, MHC DN-alpha antibody, MHC DZ alpha antibody, MHC class II antigen DOA antibody
-
UniProt
- P06340
-
Pathways
- Human Leukocyte Antigen (HLA) in Adaptive Immune Response
Target
-